References
- 1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119:e391-479.
- 2. Wibulpolprasert S, Sirilak S, Ekachampaka P, Wattanamano N, Taverat R. Thailand Health Profile 2005-2007. Bangkok: The War Veterans Organization of Thailand; 2007.
- 3. Rector TS. A conceptual model of quality of life in relation to heart failure. J Card Fail. 2005; 11:173-6.10.1016/j.cardfail.2004.09.002
- 4. Evangelista LS, Moser DK, Westlake C, Hamilton MA, Fonarow GC, Dracup K. Impact of obesity on quality of life and depression in patients with heart failure. Eur J Heart Fail. 2006; 8:750-5.
- 5. Franzen K, Blomqvist K, Saveman BI. Impact of chronic heart failure on elderly persons’ daily life: a validation study. Eur J Cardiovasc Nurs. 2006; 5:137-45.10.1016/j.ejcnurse.2005.09.003
- 6. Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005; 60:183-93.10.1111/j.1365-2125.2005.02387.x
- 7. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999; 19:860-9.10.1592/phco.19.10.860.31565
- 8. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, Otero CM, Montes AO, Garcia AN, et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med. 2005; 165:1274-9.
- 9. Rascati KL. Essentials of pharmacoeconomics. Philadelphia: Lippincott Williams & Wilkins; 2009.
- 10. Rector TS, Kubo SH, Cohn JN. Patients’ selfassessment of their congestive heart failure: content, reliability and validity of a new measure, the Minnesota Living With Heart Failure Questionnaire. Heart Fail. 1987; 3:198-209.
- 11. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993; 71:1106-7.
- 12. Guyatt GH, Nogradi S, Halcrow S, Singer J, Sullivan MJ, Fallen EL. Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med. 1989; 4:101-7.10.1007/BF02602348
- 13. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000; 35: 1245-55.10.1016/S0735-1097(00)00531-3
- 14. Morgan K, McGee H, Shelley E. Quality of life assessment in heart failure interventions: a 10-year (1996-2005) review. Eur J Cardiovasc Prev Rehabil. 2007; 14:589-607.
- 15. Bennett SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, et al. Discriminant properties of commonly used quality of life measures in heart failure. Qual Life Res. 2002; 11:349-59.10.1023/A:1015547713061
- 16. Bennett SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, et al. Comparison of quality of life measures in heart failure. Nurs Res. 2003; 52:207-16.10.1097/00006199-200307000-00001
- 17. Garin O, Soriano N, Ribera A, Ferrer M, Pont A, Alonso J, et al. Validation of the Spanish version of the Minnesota Living with Heart Failure Questionnaire. Rev Esp Cardiol. 2008; 61:251-9.10.1157/13116652
- 18. Saccomann IC, Cintra FA, Gallani MC. Psychometric properties of the Minnesota Living with Heart Failure- Brazilian version in the elderly. Qual Life Res. 2007; 16:997-1005.10.1007/s11136-007-9170-z
- 19. Eurich DT, Johnson JA, Reid KJ, Spertus JA. Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes. 2006; 4:89.
- 20. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36) II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993; 31:247-63.
- 21. Leurmarnkul W, Meetam P. Properties testing of the retranslated SF-36 (Thai version). Thai J Pharm Sci. 2005; 29:69-88.
- 22. Tangsatitkiat W, Sakthong P. The Content Improvements of the Thai Version of the Minnesota Living with Heart Failure Questionnaire, using cognitive interview. Thai Pharm Health Sci J. 2009; 4: 227-35.
- 23. Maindal HT, Sokolowski I, Vedsted P. Translation, adaptation and validation of the American Short Form Patient Activation Measure (PAM13) in a Danish version. BMC Public Health. 2009; 9:209.10.1186/1471-2458-9-209
- 24. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and qualityof- life instruments: attributes and review criteria. Qual Life Res. 2002; 11:193-205.
- 25. Rosner B. Fundamental of Biostatistics. 5th ed. California: Duxbury Thomson Learning; 2000.
- 26. Cohen J, Cohen P. Applied multiple regression/ correlation analysis for the behavioral sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates; 1983.
- 27. Ozer ZC, Firat MZ, Bektas HA. Confirmatory and exploratory factor analysis of the caregiver quality of life index-cancer with Turkish samples. Qual Life Res. 2009; 18:913-21.10.1007/s11136-009-9503-1
- 28. Fayors P, Hays R. Assessing quality of life in clinical trials: Methods and Practice. 2nd ed. New York: Oxford University Press; 2005.
- 29. Cohen J. A power primer. Psychol Bull. 1992; 112: 155-9.
- 30. Ho CC, Clochesy JM, Madigan E, Liu CC. Psychometric evaluation of the chinese version of the Minnesota Living with Heart Failure Questionnaire. Nurs Res. 2007; 56:441-8.
- 31. Heo S, Moser DK, Riegel B, Hall LA, Christman N. Testing the psychometric properties of the Minnesota Living with Heart Failure Questionnaire. Nurs Res. 2005; 54:265-72.
- 32. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999; 37: 469-78.
- 33. Wyrwich KW. Minimal important difference thresholds and the standard error of measurement: is there a connection? J Biopharm Stat. 2004; 14:97-110.10.1081/BIP-120028508